v3.23.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Commercialization revenue $ 793 $ 0 $ 1,677 $ 0
License and collaboration revenue 164 51,579 506 58,893
Total revenue 957 51,579 2,183 58,893
Costs and operating expenses:        
Cost of commercialization revenue 2,895 0 3,111 0
Research and development expenses 56,141 64,898 118,297 139,861
General and administrative expenses 13,335 18,813 27,207 39,384
Total costs and operating expenses 72,371 83,711 148,615 179,245
Loss from operations (71,414) (32,132) (146,432) (120,352)
Other income (expense), net:        
Interest income 1,695 704 3,497 932
Interest expense (1,378) (129) (2,714) (133)
Gain on sale of ATOM Facility 0 50,237 0 50,237
Other income (expense), net (10) (214) (207) (323)
Total other income (expense), net 307 50,598 576 50,713
(Loss) income before provision for income taxes (71,107) 18,466 (145,856) (69,639)
Provision for income taxes 1 0 23 0
Net (loss) income (71,108) 18,466 (145,879) (69,639)
Other comprehensive gain (loss):        
Unrealized gain (loss) on available-for-sale securities 304 (726) 1,134 (2,250)
Comprehensive (loss) income $ (70,804) $ 17,740 $ (144,745) $ (71,889)
Basic (loss) earnings per common share $ (0.68) $ 0.18 $ (1.40) $ (0.69)
Diluted (loss) earnings per common share $ (0.68) $ 0.18 $ (1.40) $ (0.69)
Basic weighted-average shares outstanding 105,091 101,601 104,533 101,166
Diluted weighted-average shares outstanding 105,091 101,866 104,533 101,166

Source